HIV-AIDS

Study examines HIV drug’s potential to treat Alzheimer’s

A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease.

In 1994, Harold “Scottie” Scott’s HIV-positive status was covered on the local news. He has been an educator ever since.

Now, 25 years after his announcement, Scott’s mission remains the same: to educate others on the history of HIV, dispel myths and break down stigma.

HIV/AIDS expert Nabel set for next Discovery Lecture

Gary Nabel, MD, PhD, Chief Scientific Officer and Senior Vice President of Sanofi, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 14.

Major grant renews AIDS education, training initiative

VUMC has been awarded a five-year, nearly $23 million federal grant to continue coordinating AIDS education and training efforts in Tennessee and seven other southeastern states.

Katrina Robertson went from death’s door to a full life. Her story is one of thousands from the first 25 years of the Vanderbilt Comprehensive Care Clinic

The VCCC opened its doors 25 years ago when AIDS was fatal and hope was rare. Today the clinic serves thousands of patients and is an international model in the treatment of people with HIV.

HIV virus

New HIV research training program launched

With the help of a $1.6 million grant from the National Heart, Lung and Blood Institute, Vanderbilt University Medical Center is launching a specialized research training program called Vanderbilt Scholars in HIV and Heart, Lung, Blood and Sleep Research, or V-SCHoLARs.

1 2 3